Cargando…

Insulin‐producing cells derived from ‘induced pluripotent stem cells’ of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis‐related genes

AIMS/INTRODUCTION: The present study was carried out to generate induced pluripotent stem cells (iPSCs) from patients with fulminant type 1 diabetes, and evaluate the cytokine‐induced apoptotic reactions of β‐like insulin‐producing cells differentiated from the iPSCs. MATERIALS AND METHODS: iPSCs we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosokawa, Yoshiya, Toyoda, Taro, Fukui, Kenji, Baden, Megu Yamaguchi, Funato, Michinori, Kondo, Yasushi, Sudo, Tomomi, Iwahashi, Hiromi, Kishida, Marina, Okada, Chihiro, Watanabe, Akira, Asaka, Isao, Osafune, Kenji, Imagawa, Akihisa, Shimomura, Iichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934265/ https://www.ncbi.nlm.nih.gov/pubmed/28796422 http://dx.doi.org/10.1111/jdi.12727

Ejemplares similares

Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue
por: Baden, Megu Yamaguchi, et al.
Publicado: (2015)

Complete loss of insulin secretion capacity in type 1A diabetes patients during long‐term follow up
por: Uno, Sae, et al.
Publicado: (2017)

Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Case of a novel PAX6 mutation with aniridia and insulin‐dependent diabetes mellitus
por: Motoda, Saori, et al.
Publicado: (2018)

Hyperinsulinemia and Insulin Receptor Gene Mutation in Nonobese Healthy Subjects in Japan
por: Fujita, Shingo, et al.
Publicado: (2017)

An Impaired Awareness of Hypoglycemia Improved After Vitamin B(12) Treatment in a Type 1 Diabetic Patient
por: Fujita, Shingo, et al.
Publicado: (2017)

Maximum body mass index before onset of type 2 diabetes is independently associated with advanced diabetic complications
por: Ozawa, Harutoshi, et al.
Publicado: (2021)

Clinical Significance of the Maximum Body Mass Index Before Onset of Type 2 Diabetes for Predicting Beta-Cell Function
por: Ozawa, Harutoshi, et al.
Publicado: (2020)

Amelioration of pancreatic fat accumulation in Japanese type 2 diabetes patients treated with sodium‐glucose cotransporter 2 inhibitors: a retrospective study
por: Horii, Tomomi, et al.
Publicado: (2021)

Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients
por: Kozawa, Junji, et al.
Publicado: (2011)

Extent of weight reduction necessary for minimization of diabetes risk in Japanese men with visceral fat accumulation and glycated hemoglobin of 5.6–6.4%
por: Iwahashi, Hiromi, et al.
Publicado: (2015)

Weight reduction is associated with improvement of glycemic control in Japanese men, whose hemoglobin A1C is 5.6–6.4%, with visceral fat accumulation, but not without visceral fat accumulation
por: Okauchi, Yukiyoshi, et al.
Publicado: (2013)

Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment
por: Motoda, Saori, et al.
Publicado: (2022)

Glucose Intolerance After Pancreatectomy Was Associated With Preoperative Hemoglobin A1c, Insulin Resistance, and Histological Pancreatic Fatty Infiltration
por: Ishibashi, Chisaki, et al.
Publicado: (2018)

Usefulness of the insulin tolerance test in patients with type 2 diabetes receiving insulin therapy
por: Okita, Kohei, et al.
Publicado: (2013)

Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study
por: Okauchi, Yukiyoshi, et al.
Publicado: (2011)

Pancreatic fat is related to the longitudinal decrease in the increment of C‐peptide in glucagon stimulation test in type 2 diabetes patients
por: Ishibashi, Chisaki, et al.
Publicado: (2019)

Increased NKX6.1 expression and decreased ARX expression in alpha cells accompany reduced beta-cell volume in human subjects
por: Fujita, Yukari, et al.
Publicado: (2021)

Adaptation of the brain to hypoglycemia: Does the brain stand by for the next hypoglycemia event?
por: Fukui, Kenji, et al.
Publicado: (2014)

Insulin‐secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non‐obese Japanese patients
por: Iwahashi, Hiromi, et al.
Publicado: (2012)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Inflammatory Cell Infiltration Into Islets Without PD-L1 Expression Is Associated With the Development of Immune Checkpoint Inhibitor–Related Type 1 Diabetes in Genetically Susceptible Patients
por: Kawata, Satoshi, et al.
Publicado: (2023)

Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic
por: Sano, Hiroyuki, et al.
Publicado: (2022)

Consumption of two meals per day is associated with increased intrapancreatic fat deposition in patients with type 2 diabetes: a retrospective study
por: Niki, Akiko, et al.
Publicado: (2022)

Human pancreatic α‐ to β‐cell area ratio increases after type 2 diabetes onset
por: Fujita, Yukari, et al.
Publicado: (2018)

Predictors of deterioration of glucose tolerance and effects of lifestyle intervention aimed at reducing visceral fat in normal glucose tolerance subjects with abdominal obesity
por: Akita, Etsuko F, et al.
Publicado: (2010)

“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018)

Relationships between intra-pancreatic fat deposition and lifestyle factors: a cross-sectional study
por: Mitsushio, Kento, et al.
Publicado: (2023)

Expansion of human alpha‐cell area is associated with a higher maximum body mass index before the onset of type 2 diabetes
por: Ozawa, Harutoshi, et al.
Publicado: (2023)

Diabetes due to Mitochondrial Adipopathy
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

Islet inflammation is associated with pancreatic fatty infiltration and hyperglycemia in type 2 diabetes
por: Horii, Tomomi, et al.
Publicado: (2020)

Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Generation of Alveolar Epithelial Spheroids via Isolated Progenitor Cells from Human Pluripotent Stem Cells
por: Gotoh, Shimpei, et al.
Publicado: (2014)

Type 2 diabetes mellitus prevention strategy: Target and goal in Japanese men
por: Iwahashi, Hiromi, et al.
Publicado: (2016)

Suppression Failure of Cortisol Secretion by Dexamethasone May Occur in Glucagon-like Peptide-1 Receptor Agonist-treated Patients with Diabetic Autonomic Neuropathy
por: Nagai, Yasuki, et al.
Publicado: (2018)

Pseudohypoglycemia or hyperglycemia caused by interference with self‐monitoring blood glucose measurements in anticancer ascorbic acid therapy
por: Kimura, Takekazu, et al.
Publicado: (2013)

Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance
por: Kozawa, Junji, et al.
Publicado: (2012)

Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010)

Whole-exome Sequencing Analysis of a Japanese Patient With Hyperinsulinemia and Liver Dysfunction
por: Fujita, Shingo, et al.
Publicado: (2022)

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
por: Kozawa, Junji, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1vnrfdlj5cb7gv743cl81bm59j